Drugs that lack single-agent activity: Are they worth pursuing in combination?

Bishal Gyawali; Vinay Prasad

doi:10.1038/nrclinonc.2017.27

Drugs that lack single-agent activity: Are they worth pursuing in combination?

Bishal Gyawali, Vinay Prasad

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

23 Scopus citations

Original language	English (US)
Pages (from-to)	193-194
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	14
Issue number	4
DOIs	https://doi.org/10.1038/nrclinonc.2017.27
State	Published - Apr 1 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/nrclinonc.2017.27

Cite this

@article{4e480c5d63bb4a3785c6c702e3411cf4,

title = "Drugs that lack single-agent activity: Are they worth pursuing in combination?",

author = "Bishal Gyawali and Vinay Prasad",

year = "2017",

month = apr,

day = "1",

doi = "10.1038/nrclinonc.2017.27",

language = "English (US)",

volume = "14",

pages = "193--194",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Drugs that lack single-agent activity

T2 - Are they worth pursuing in combination?

AU - Gyawali, Bishal

AU - Prasad, Vinay

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85014548814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014548814&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2017.27

DO - 10.1038/nrclinonc.2017.27

M3 - Comment/debate

C2 - 28266519

AN - SCOPUS:85014548814

SN - 1759-4774

VL - 14

SP - 193

EP - 194

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 4

ER -

Drugs that lack single-agent activity: Are they worth pursuing in combination?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this